Search
Aug 9, 2023
Alltrna raises $109 million in a Series B financing to advance tRNA based therapies
Michelle Werner explains the science behind how Alltrna is trying to harness transfer RNA to develop therapies for stop codon diseases.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.